June 2006
		EDITOR'S PAGE Welcome to the Second Issue of Retina Today By Conni Koury, Editor-in-Chief MEDICAL RETINA New Molecular Targets in the Treatment of Ocular Neovascular Diseases By David T. Shima, PhD, and Anthony P. Adamis, MD MACULA Intravitreal Bevacizumab for the Treatment of Subfoveal CNV Secondary to AMD By Caroline R. Baumal, MD, and David Eichenbaum, MD Angiographic Interpretation of Neovascular AMD by Different ‘Reading Centers’ By Michael S. Ip, MD Subthreshold Laser Not Protective in Eyes With Drusen By Conni Bergmann Koury, Editor-in-Chief Monotherapy vs Combination Therapy for Wet AMD: Is Ranibizumab the Insulin of AMD? By David M. Brown, MD, and Tom Sheidow, MD, FRCS(C) DIABETES Ruboxistaurin: Useful in Preventing Visual Loss in Diabetic Patients By Laura Suarez, Managing Editor Rosiglitazone May Delay Progression to PDR By Conni Bergmann Koury, Editor-in-Chief Pegaptanib May Improve Diabetic Retinopathy By Laura Suarez, Managing Editor RETINAL IMAGING Quantification and Volumetric Imaging of Retinal Pathologies Using High-Speed Ultrahigh Resolution OCT By Conni Bergmann Koury, Editor-in-Chief COVER FOCUS Miniaturized Instruments in Vitreoretinal Surgery: The Future? By Barbara Wimpissinger, MD; Lukas Kellner, MD; Ulrike Stolba, MD; and Susanne Binder, MD Results of the SPR Study: Scleral Buckling vs Primary Vitrectomy in Retinal Detachment By Conni Bergmann Koury, Editor-in-Chief Autologous Transplantation of RPE for the Management of Acute Exudative AMD By Robert E. MacLaren, FRCOphth, FRCS, DPhil Clinical Trials Continuing Medical Education 5 Questions: 2006 ARVO Award Winners